FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

TINA-QUANT HBA1C GEN.2

K Number: K110313 · Decision Dec 23, 2011
Classifications
1
FEI Numbers
65
Registration Numbers
65
Same Product Code
248
Applicant Total
183
Review Days
324

Basic Information

Device Name
TINA-QUANT HBA1C GEN.2
K Number
K110313
Device Class
FDA class 2
Clearance Type
Traditional
Regulation Number
864.7470
Medical Specialty
Hematology
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Roche Diagnostics
Date Received
February 2, 2011
Decision Date
December 23, 2011
Product Code
LCP
Advisory Committee
Hematology
Review Advisory Committee
CH
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
LCP Assay, Glycosylated Hemoglobin

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (LCP), ordered by most recent decision date.

View all

Other Clearances by Roche Diagnostics

K Number Device Name
K252323 cobas pulse blood glucose monitoring system
K252280 Elecsys Anti-SARS-CoV-2 S
K260048 Elecsys Anti-HAV IgM
K260049 Elecsys Anti-HBc IgM
K260046 Elecsys Anti-HBc II
K260026 Tina-quant Cardiac high sensitivity CRP III
K253490 Glucose HK Gen.3; ONLINE DAT Methadone II; cobas pro integrated solutions
K253491 ISE indirect K for Gen.2; ISE indirect Na for Gen.2; ISE indirect Cl for Gen.2; cobas pro integrated solutions
K253839 Elecsys Anti-SARS-CoV-2
K253188 CoaguChek XS Plus System
Search all 183 clearances from Roche Diagnostics →